U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C11H16N4O4
Molecular Weight 268.2691
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of RAZOXANE

SMILES

CC(CN1CC(=O)NC(=O)C1)N2CC(=O)NC(=O)C2

InChI

InChIKey=BMKDZUISNHGIBY-UHFFFAOYSA-N
InChI=1S/C11H16N4O4/c1-7(15-5-10(18)13-11(19)6-15)2-14-3-8(16)12-9(17)4-14/h7H,2-6H2,1H3,(H,12,16,17)(H,13,18,19)

HIDE SMILES / InChI
Molecular Formula C11H16N4O4
Molecular Weight 268.2691
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Approval Year

Unknown
86413
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:47:11 UTC 2023
Edited
by admin
on Fri Dec 15 15:47:11 UTC 2023
Record UNII
5AR83PR647
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
RAZOXANE
INN   MART.   MI   WHO-DD  
INN  
Official Name English
ICRF-159
Code English
RAZOXANE [MI]
Common Name English
NSC-129943
Code English
ICRF 159
Code English
Razoxane [WHO-DD]
Common Name English
(±)-4,4'-PROPYLENEDI-2,6-PIPERAZINEDIONE
Systematic Name English
ICI 59118
Code English
RAZOXANE [MART.]
Common Name English
razoxane [INN]
Common Name English
ICI-59118
Code English
2,6-PIPERAZINEDIONE, 4,4'-(1-METHYL-1,2-ETHANEDIYL)BIS-
Systematic Name English
Classification Tree Code System Code
NCI_THESAURUS C360
Created by admin on Fri Dec 15 15:47:11 UTC 2023 , Edited by admin on Fri Dec 15 15:47:11 UTC 2023
Code System Code Type Description
CAS
83713-23-9
Created by admin on Fri Dec 15 15:47:11 UTC 2023 , Edited by admin on Fri Dec 15 15:47:11 UTC 2023
SUPERSEDED
CAS
78673-26-4
Created by admin on Fri Dec 15 15:47:11 UTC 2023 , Edited by admin on Fri Dec 15 15:47:11 UTC 2023
SUPERSEDED
NSC
129943
Created by admin on Fri Dec 15 15:47:11 UTC 2023 , Edited by admin on Fri Dec 15 15:47:11 UTC 2023
PRIMARY
INN
3675
Created by admin on Fri Dec 15 15:47:11 UTC 2023 , Edited by admin on Fri Dec 15 15:47:11 UTC 2023
PRIMARY
NCI_THESAURUS
C801
Created by admin on Fri Dec 15 15:47:11 UTC 2023 , Edited by admin on Fri Dec 15 15:47:11 UTC 2023
PRIMARY
CHEBI
50225
Created by admin on Fri Dec 15 15:47:11 UTC 2023 , Edited by admin on Fri Dec 15 15:47:11 UTC 2023
PRIMARY
CAS
35259-82-6
Created by admin on Fri Dec 15 15:47:11 UTC 2023 , Edited by admin on Fri Dec 15 15:47:11 UTC 2023
SUPERSEDED
MERCK INDEX
m9511
Created by admin on Fri Dec 15 15:47:11 UTC 2023 , Edited by admin on Fri Dec 15 15:47:11 UTC 2023
PRIMARY Merck Index
ECHA (EC/EINECS)
244-379-2
Created by admin on Fri Dec 15 15:47:11 UTC 2023 , Edited by admin on Fri Dec 15 15:47:11 UTC 2023
PRIMARY
FDA UNII
5AR83PR647
Created by admin on Fri Dec 15 15:47:11 UTC 2023 , Edited by admin on Fri Dec 15 15:47:11 UTC 2023
PRIMARY
CAS
21416-67-1
Created by admin on Fri Dec 15 15:47:11 UTC 2023 , Edited by admin on Fri Dec 15 15:47:11 UTC 2023
PRIMARY
RXCUI
9154
Created by admin on Fri Dec 15 15:47:11 UTC 2023 , Edited by admin on Fri Dec 15 15:47:11 UTC 2023
PRIMARY RxNorm
SMS_ID
100000080822
Created by admin on Fri Dec 15 15:47:11 UTC 2023 , Edited by admin on Fri Dec 15 15:47:11 UTC 2023
PRIMARY
EVMPD
SUB10266MIG
Created by admin on Fri Dec 15 15:47:11 UTC 2023 , Edited by admin on Fri Dec 15 15:47:11 UTC 2023
PRIMARY
MESH
D011929
Created by admin on Fri Dec 15 15:47:11 UTC 2023 , Edited by admin on Fri Dec 15 15:47:11 UTC 2023
PRIMARY
PUBCHEM
30623
Created by admin on Fri Dec 15 15:47:11 UTC 2023 , Edited by admin on Fri Dec 15 15:47:11 UTC 2023
PRIMARY
ChEMBL
CHEMBL444186
Created by admin on Fri Dec 15 15:47:11 UTC 2023 , Edited by admin on Fri Dec 15 15:47:11 UTC 2023
PRIMARY
DRUG CENTRAL
4031
Created by admin on Fri Dec 15 15:47:11 UTC 2023 , Edited by admin on Fri Dec 15 15:47:11 UTC 2023
PRIMARY
CAS
21416-87-5
Created by admin on Fri Dec 15 15:47:11 UTC 2023 , Edited by admin on Fri Dec 15 15:47:11 UTC 2023
SUPERSEDED
EPA CompTox
DTXSID0020733
Created by admin on Fri Dec 15 15:47:11 UTC 2023 , Edited by admin on Fri Dec 15 15:47:11 UTC 2023
PRIMARY
Related Record Type Details
Structure of RAZOXANE, (R)-
ENANTIOMER -> RACEMATE
Structure of DEXRAZOXANE
ENANTIOMER -> RACEMATE
Structure of RAZOXANE HYDROCHLORIDE
SALT/SOLVATE -> PARENT
Related Record Type Details
Structure of RAZOXANE
ACTIVE MOIETY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966